Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

High Intensity Focused Ultrasound as a Treatment for Rectal and Pelvic Cancers - Laboratory and Clinical Feasibility Studies

NCT03595722 is registered in ClinicalTrials.gov with Imperial College London as lead sponsor.

NCT NCT03595722
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03595722 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
High Intensity Focused Ultrasound as a Treatment for Rectal and Pelvic Cancers - Laboratory and Clinical Feasibility Studies
Lead sponsor
Imperial College London
Phase
Not applicable
Overall status
Unknown status
Start date
July 11, 2019
Completion date
August 28, 2022
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cervical cancer, endometrial cancer, pelvic cancer, rectal cancer, rectal neoplasms